**Core Concept**
Tacrolimus is an immunosuppressive agent used primarily to prevent organ rejection in transplant patients. It functions by inhibiting the activation of T-lymphocytes, which play a crucial role in the immune response.

**Why the Correct Answer is Right**
Tacrolimus belongs to the class of calcineurin inhibitors, which act by binding to the immunophilin FKBP-12. This complex then inhibits the activity of calcineurin, a phosphatase enzyme responsible for dephosphorylating and activating the nuclear factor of activated T-cells (NFAT). As a result, the transcription of IL-2 and other cytokines is suppressed, leading to reduced T-cell activation and proliferation.

**Why Each Wrong Option is Incorrect**
**Option A:** Incorrect, as corticosteroids are a different class of immunosuppressants that act by modulating the immune response through various mechanisms, including the inhibition of inflammation and lymphocyte activation.
**Option B:** Incorrect, as azathioprine is an antimetabolite that interferes with DNA synthesis and is not a calcineurin inhibitor.
**Option C:** Incorrect, as sirolimus (also known as rapamycin) is a different class of immunosuppressant that acts by inhibiting the mammalian target of rapamycin (mTOR), leading to reduced T-cell activation and proliferation.

**Clinical Pearl / High-Yield Fact**
Tacrolimus is known for its narrow therapeutic index and potential for nephrotoxicity, making monitoring of serum levels and renal function crucial in patients receiving this medication.

**Correct Answer:** C. Calcineurin inhibitors.